Categories Earnings, Finance

TD Ameritrade (AMTD): Q4 2019 Earnings Snapshot

— TD Ameritrade Holding Corporation (NASDAQ: AMTD) reported fourth-quarter 2019 adjusted earnings of $1.05 per share versus $0.98 per share expected.

— Net revenues increased by 11% to $1.56 billion versus $1.47 billion expected. The results were driven by higher asset-based revenues and an increase in commissions and transaction fees.

Earnings Update by AlphaStreet

— Average client trades per day rose by 5% to about 837,000. Net new client assets increased at an annualized rate of 7% to about $22 billion.

— Total trades rose by 7% to 53.2 million while average commissions per trade declined to $7.04 from $7.35 a year ago.

— For the first-quarter of 2020, earnings are expected to fall due to the elimination of commissions for the online exchange-listed stock, ETF and option trades from $6.95 to $0.

Read: Online brokers sink amid commission-free trades

— For fiscal 2020, the company expects revenue in the range of $4.9 billion to $5.3 billion and an operating expense of $2.8 billion to $3 billion.

— The company will lift quarterly cash dividend by $0.01 per share for fiscal 2020 to $0.31, a 3% increase from fiscal 2019. It has declared a $0.31 per share quarterly cash dividend, payable on November 19, 2019, to all holders of record of common stock as of November 5, 2019.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Also Read:  Buoyed by retail banking, JPMorgan tames interest rate woes in Q3

Most Popular

BlackBerry (BB) likely to report weak Q4 earnings on March 31

BlackBerry Limited (NYSE: BB) is slated to report its fourth-quarter 2020 earnings results on Tuesday, March 31, after the market closes. The top line will be benefited by BlackBerry Cylance

Companies that are working on the coronavirus vaccine

The coronavirus pandemic continues to plague the world with over 500,000 cases reported globally and over 82,000 cases in the US alone. As the world grapples with the outbreak, several

Altimmune (ALT) reports FY19 results; announces vaccine candidate for COVID-19

Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year 2019. Revenues totaled $5.8 million compared to $10.3 million last year. The drop in revenues was caused by lower billings